Medigen Biotechnology Net Asset Quality Index
Medigen Biotechnology net asset quality index. Medigen Biotechnology (3176) has a Net Asset Quality Index of 77.2% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$6.34 Billion minus total liabilities of NT$1.45 Billion yields net assets of NT$4.90 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 3176 net asset value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Medigen Biotechnology (2003–2024)
Net asset quality index of Medigen Biotechnology from 2003 to 2024. This chart shows how Medigen Biotechnology's Net Asset Quality Index has evolved across 22 annual periods from 2003 to 2024. As of September 2025, the index stands at 77.2%, representing net assets of NT$4.90 Billion against total assets of NT$6.34 Billion TWD. Check Medigen Biotechnology PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Medigen Biotechnology Net Asset Quality Index by Year (2003–2024)
Medigen Biotechnology net asset quality index by year from 2003 to 2024. The table below presents the year-by-year Net Asset Quality Index for Medigen Biotechnology from 2003 to 2024, covering 22 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 3176 stock market capitalisation.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 75.1% | NT$5.04 Billion | NT$6.71 Billion | NT$1.67 Billion | ▲ +16.5 pp |
| 2023 | 58.6% | NT$5.00 Billion | NT$8.53 Billion | NT$3.53 Billion | ▼ -6.2 pp |
| 2022 | 64.8% | NT$6.47 Billion | NT$9.98 Billion | NT$3.51 Billion | ▼ -13.5 pp |
| 2021 | 78.4% | NT$6.43 Billion | NT$8.20 Billion | NT$1.77 Billion | ▲ +5.2 pp |
| 2020 | 73.1% | NT$4.50 Billion | NT$6.15 Billion | NT$1.65 Billion | ▲ +17.5 pp |
| 2019 | 55.6% | NT$2.69 Billion | NT$4.83 Billion | NT$2.14 Billion | ▼ -8.3 pp |
| 2018 | 64.0% | NT$2.94 Billion | NT$4.60 Billion | NT$1.66 Billion | ▼ -1.3 pp |
| 2017 | 65.3% | NT$3.18 Billion | NT$4.87 Billion | NT$1.69 Billion | ▼ -8.1 pp |
| 2016 | 73.4% | NT$3.54 Billion | NT$4.82 Billion | NT$1.28 Billion | ▼ -3.7 pp |
| 2015 | 77.1% | NT$3.46 Billion | NT$4.49 Billion | NT$1.03 Billion | ▼ -4.9 pp |
| 2014 | 82.0% | NT$3.66 Billion | NT$4.46 Billion | NT$804.40 Million | ▼ -11.1 pp |
| 2013 | 93.1% | NT$3.07 Billion | NT$3.29 Billion | NT$226.84 Million | ▲ +1.4 pp |
| 2012 | 91.7% | NT$2.05 Billion | NT$2.24 Billion | NT$186.42 Million | ▲ +16.3 pp |
| 2011 | 75.4% | NT$915.79 Million | NT$1.21 Billion | NT$298.81 Million | ▼ -17.5 pp |
| 2010 | 92.9% | NT$807.90 Million | NT$869.78 Million | NT$61.88 Million | ▲ +5.0 pp |
| 2009 | 87.9% | NT$597.02 Million | NT$679.27 Million | NT$82.25 Million | ▲ +8.6 pp |
| 2008 | 79.2% | NT$539.65 Million | NT$680.98 Million | NT$141.33 Million | ▲ +0.2 pp |
| 2007 | 79.0% | NT$468.68 Million | NT$593.03 Million | NT$124.35 Million | ▼ -10.9 pp |
| 2006 | 89.9% | NT$667.93 Million | NT$742.89 Million | NT$74.96 Million | ▼ -2.7 pp |
| 2005 | 92.6% | NT$650.39 Million | NT$702.17 Million | NT$51.78 Million | ▼ -3.7 pp |
| 2004 | 96.3% | NT$739.26 Million | NT$767.53 Million | NT$28.26 Million | ▲ +7.7 pp |
| 2003 | 88.6% | NT$856.65 Million | NT$966.81 Million | NT$110.16 Million | — |